The DOI matches its Crossref record.
Diagnosis of Alzheimer's Disease
Abstract
Early and accurate diagnosis of Alzheimer's disease (AD) has a major impact on the progress of research on dementia. To address the problems involved in diagnosing AD in its earliest stages, the National Institute on Aging, the American Association of Retired Persons, the National Institute of Neurological and Communicative Disorders and Stroke, and the National Institute of Mental Health jointly sponsored a workshop for planning research. The purpose of the meeting was to identify the most important scientific research opportunities and the crucial clinical and technical issues that influence the progress of research on the diagnosis of AD. The 37 participants included some of the most knowledgeable and eminent scientists and physicians actively involved in the study of AD. The participants were divided among six panels representing the disciplines of neurochemistry, neuropathology, neuroradiology, neurology, neuropsychology, and psychiatry. Within each of the panels, participants discussed specific areas of research requiring further
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This contrasts to the original set of criteria produced in 1985 by the National Institute on Aging, which focused on age-related amyloid plaque density (with silver stains or thioflavin S fluorescent microscopy) without regard to type of plaque [108].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [108]
In the citing paper
“there have been several changes in neuropathological diagnostic criteria, including the “Khachaturian criteria” of 1985 (27), the “Tierney” criteria of 1988 (28), The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) criteria in 1991 (29), and the National Institute on Aging (NIA)-Reagan criteria in 1997 (30).”
From Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 (2012) · cites this paper as [27]
Citations
Cited by
Sorted by citations
Items 1,001–1,068 of 1,068
A New Hypothesis (Concept) of Diagnosing Alzheimer's Disease
Chan, D. K. Y. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.10.m645 · Cited by 3
Alzheimer's disease: a neuropathologic perspective
Vinters, H. (1998) · Current Diagnostic Pathology · doi:10.1016/s0968-6053(98)80019-7 · Cited by 2
Prospects of Developing Interventions to Prevent Alzheimer's Disease
Khachaturian, Z. (1998) · Pharmacotherapy · doi:10.1002/j.1875-9114.1998.tb03881.x · Cited by 2
Self-citationAssociation of urodynamic function and brain neuropathology in elderly institutionalized patients.
Starer, P. (1997) · Archives of gerontology and geriatrics (Print) · doi:10.1016/s0167-4943(97)00007-1 · Cited by 2
Tau Protein in Cerebrospinal Fluid. A Potential Marker of Alzheimer's Disease.
Arai, H., Satoh, K., Terajima, M., Nakagawa, T., Higuchi, M., Kosaka, Y., Zhu, C., & Sasaki, H. (1996) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.33.669 · Cited by 2
Neuropathological Diagnosis of Dementia Using Silver Stains and Immunohistochemical Techniques
Powers, R., & Wilson, D. (1996) · doi:10.1179/his.1996.19.3.235 · Cited by 2
Poirier, J., Beffert, U., Dea, D., Alonso, R., O'Donnell, D., & Boksa, P. (1995) · Brain Research. Molecular Brain Research · doi:10.1016/0169-328x(95)00134-e · Cited by 2
Garvey, W., Fathi, A., & Bigelow, F. (1994) · doi:10.1179/his.1994.17.4.353 · Cited by 2
Re-evaluation of classic senile plaques by three-dimensional analysis
Kimura, T., Hisano, T., Yoshida, H., Ueda, K., & Miyakawa, T. (1994) · Journal of Neurology · doi:10.1007/bf00920628 · Cited by 2
Ikeda, K. (1994) · Neuropathology · doi:10.1111/j.1440-1789.1994.tb00247.x · Cited by 2
Epidemiology of alzheimer's disease: Research trends in the united states
de Figueiredo, J. M. (1993) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930080110 · Cited by 1
Bodenteich, A., Mitchell, L. G., Merril, C., Miller, B., Ghanbari, H., & Heegaard, N. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90202-v · Cited by 2
Phytopharmacology in Alzheimer’s Disease: A Review of Iranian Traditional Medicine
Kiani, A. (2026) · Plant Biotechnology Persa · doi:10.66224/pbp.8.2.5 · Cited by 1
Synthesis of benzylidene-indandione derivatives as quantification of amyloid fibrils.
Ghadami, S., Ahadi-Amandi, K., Khodarahmi, R., Ghanbari, S., & Adibi, H. (2023) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.106982 · Cited by 1
Investigation of the Relationship Between Polymorphism in miR-34b/c and Risk of Alzheimer's Disease
Paskeh, M. D. A., Salehi, Z., & Ghayeghran, A. (2022) · Journal of Human Genetics and Genomics · doi:10.5812/jhgg-123627 · Cited by 1
“Four Risk alleles have been identified for over 500 genes with susceptible genetic variations (4).”
BackgroundAβ Imaging in Aging, Alzheimer’s Disease, and Other Neurodegenerative Conditions
Villemagne, V. L., Doré, V., Burnham, S. C., & Rowe, C. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_10 · Cited by 2
Kumar, V., & Saha, A. (2020) · International Journal of Quantitative Structure-Property Relationships · doi:10.4018/ijqspr.2020070102 · Cited by 1
Thapa, N., Jeong, Y., Kang, H., Choi, G.-E., Yoon, H., & Kang, D.-Y. (2019) · Biomedical Science Letters · doi:10.15616/bsl.2019.25.1.7 · Cited by 1
“Although some quantities of Aβ plaques can be found in cognitively normal elderly people (Aizenstein et al., 2008), AD diagnosis is made with the presence of both plaques and cognitive impairment (Khachaturian, 1985; Hsiao et al., 1996).”
BackgroundKarla, R., Alfonso, D. F., Blanca, E., Felipe, M., Hugo, D., Francine, G., Yves, J., Yves, R., & Jorge, G. (2014) · Advances in Aging Research · doi:10.4236/aar.2014.33033 · Cited by 1
“9 years old) diagnosed clinically and histopathologically by two neuropathologists according to the NINCDS/RCDA criterion [16] [17].”
MethodCXB-909 Attenuates Cognitive Deficits in the Mu-P-75 Saporin Mouse Model of Alzheimer’s Disease
Lowrance, S. A., Matchynski, J., Rossignol, J., DeKorver, N. W., Sandstrom, M., & Dunbar, G. (2012) · Neuroscience & Medicine · doi:10.4236/nm.2012.31010 · Cited by 1
“of amyloid-beta plaques, neurofibrillary tangles [1], and loss of cholinergic neurons of the basal forebrain, which lead to memory loss [2].”
BackgroundNeuroimaging Studies in Alzheimer's Disease
Cuellar, H., Gómez‐Ramos, P., Riascos, R., & Alba, L. D. (2009) · The Neuroradiology Journal · doi:10.1177/197140090902200503
Características neuropatológicas y moleculares de la enfermedad de Alzheimer
Rodrigo, J., Martínez, A., Fernández, A. P., Serrano, J., Bentura, M. L., Moreno, E., Aparicio, M., Martínez‐Murillo, R., & Regidor, J. (2007) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(07)73533-3 · Cited by 1
Brown, D. F., & White, C. L. (1997) · Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders · doi:10.1044/nnsld7.4.11
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Imaging of Neurotransmitter Systems in Dementia
Hasselbalch, S., & Knudsen, G. (2016) · CRC Press eBooks · doi:10.3109/9781420016819-12
Aumont‐Rodrigue, G., Picard, C., Sarty, I. M., Savard, M., & Poirier, J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107641
Josephs, K. A., Weigand, S. D., Satoh, R., Lavrova, A., Tapia, A. L., Graff‐Radford, J., Machulda, M. M., Kantarci, K., Boeve, B. F., Petersen, R. C., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117530
Ghosh, P., Mukhopadhyay, S., Rati, S., Ghosh, S., & Iyer, P. K. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c01210
Behavioral Variant in Alzheimer's Disease.
Wu, C.-K., Dailey, J. M., & Donahue, J. E. (2026) · Acta neurologica Taiwanica · doi:10.4103/ant.ant-d-25-00098
Alzheimer’s Disease Classification using MRI-based Lightweight CNN–Transformer
Yun, T., Kim, S., Ryu, J.-Y., & Ha, J. (2025) · The Journal of Korean Institute of Information Technology · doi:10.14801/jkiit.2025.23.11.181
Honnorat, N., Mojtabai, M., Li, K., Li, J., Martinez, D. E., Rashid, T., Smith, M., Flanagan, M. E., Fadaee, E., Torres, M. F., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103752
“Histopathology was of critical importance to describe neurodegenerative disorders and understand how they affect the brain (Khachaturian, 1985; Hyman, 1997).”
IoT Assistant-Based Secured System for Alzheimer’s Disease
Gabriel, G., & Nachappa, M. N. (2024) · International Journal of Advanced Research in Science, Communication and Technology · doi:10.48175/ijarsct-15960
Early Detection of Alzheimer’s Disease using CNN with PSO for parameter optimization
Harwalkar, J., Reddy, M. H., Shravani, M., Samptur, N., & Priya, L. K. (2023) · IEEE International Conference on Contemporary Computing and Communications (InC4) · doi:10.1109/inc457730.2023.10262877
“The risk of getting this disease increases with age and it is mostly seen in older people like at an age of 60 [2].”
BackgroundEditorial: Machine Learning for Non/Less-Invasive Methods in Health Informatics
Qian, K., Zhang, L., Li, K., & Liu, J. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.763109
“, Alzheimer’s disease (AD) (3), can be very much important essential for benefiting guaranteeing a safe, easy, and independent life for the elderly, particularly for those who are living alone.”
Backgroundvan Rheenen, R. V., Stormezand, G., van Amerongen, J. V., Otte, A., de Deyn, P., & Dierckx, R. (2020) · PET and SPECT in Neurology · doi:10.1007/978-3-642-54307-4_14
Ibañez, L., Bahena, J., Yang, C.-R., Dube, U., Farias, F., Budde, J., Bergmann, K., Brenner-Webster, C., Morris, J., Perrin, R., et al. (2020) · medRxiv · doi:10.1101/2020.07.01.20144493
Victoroff, J. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139696432.013
Taylor, B. (2016) · IU Journal of Undergraduate Research · doi:10.14434/iujur.v2i1.20925
Grachev, I. D. (2015) · Journal of Neurology & Stroke · doi:10.15406/jnsk.2015.02.00050
Cognitive Enhancers and Treatments for Alzheimer's Disease
Devanand, D. P. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch109
Whole Exome Analysis of Early Onset Alzheimer's Disease
Pericak-Vance, M. (2013) · doi:10.21236/ada603027
Resting state brain networks and their implications in neurodegenerative disease
Sohn, W. S., Yoo, K., Kim, J., & Jeong, Y. (2012) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2000254
Alzheimer's Disease: Clinical Aspects
Turner, R. (2012) · CRC Press eBooks · doi:10.1201/b11986-7
Vascular dementia: why pathology is still important
Neal, J. (2011) · Reviews in Clinical Gerontology · doi:10.1017/s0959259811000207 · Cited by 2
Thinking Outside the Box in Alzheimer Disease Treatment
Castellani, R. J., Marlatt, M. W., Nunomura, A., Moreira, P. I., Lee, H., Casadesús, G., Zhu, X., Perry, G. L., & Smith, M. A. (2011) · Wiley eBooks · doi:10.1002/9780470571224.pse457
New Thinking on the Etiology and Pathogenesis of Late‐Onset Alzheimer′s Disease
Hudson, A. P., Balin, B. J., Crutcher, K. A., & Robinson, S. R. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/848395 · Cited by 1
Diffusion Abnormality of Corpus Callosum in Alzheimer's Disease
FindikoğLu, A., Ercan, K., & Gunbey, H. (2011) · The Neuroradiology Journal · doi:10.1177/197140091102400204
Animal Models to Study the Biology of Amyloid‐β Protein Misfolding in Alzheimer Disease
Ashe, K. H. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch11
Bétard, C., Boneschi, F. M., & Caramelli, P. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse237
Nutrition et fonctions cognitives
Michel, J. (2007) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/s1627-4830(07)89962-4
Laboratory Diagnosis of Dementia
Cruz, K. S. S. (2006) · doi:10.1309/5027tla3d9d1jvhj
Commentary on “Diagnosis of Alzheimer's disease: Two decades of progress”
Katzman, R. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.09.010
Ye, W., Liu, J., Zhou, J.-N., Hu, X., & Tang, X.-W. (2005) · doi:10.1007/bf02897380
Neuroimaging Abnormalities in Drug Addiction and Alcoholism
Schiffer, W., Marsteller, D., & Dewey, S. (2003) · doi:10.3109/9780203912485-41
Shepstone, B. (2000) · doi:10.1258/136218000129569449
Autopsy in dementing disorders of the elderly
Ince, P. (2000) · Current Diagnostic Pathology · doi:10.1054/cdip.2000.0034
Apolipoprotein E and Neurofibrillary Tangles in Alzheimer's Disease
Ohm, T., Scharnagl, H., & März, W. (1998) · KARGER eBooks · doi:10.1159/000059503
Esiri, M. (1998) · The Journal of the British Menopause Society · doi:10.1177/136218079800400209
Baik, T., Leech, R., & Brumback, R. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90274-2
Current Diagnostic Criteria for Assessment of Neuropathological Alzheimer’s Disease
Gambetti, P. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00060-2 · Cited by 1
Pathology, Neurobiology, and Animal Models of Alzheimer's Disease
Sisodia, S. S., Price, D. D., Crain, B. J., & Troncoso, J. C. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch12 · Cited by 3
Cserni, G. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90284-8
La diagnostica neuroradiologica TC nelle demenze
Zanotti, B., Bruseghini, C., & Leonardi, M. (1995) · Rivista di Neuroradiologia · doi:10.1177/197140099500800409
Non‐cognitive psychiatric symptoms in vascular and Alzheimer brain disease
Birkett, D., & Agdeppa, J. (1995) · doi:10.1002/gps.930100810
CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS
Sisodia, S. S., Martin, L. J., Walker, L. C., Borchelt, D., & Price, D. L. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00276-x · Cited by 6
Metadata
- Authors
- Khachaturian, Z. S.
- Corresponding author
- Khachaturian, Z. S.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 1985-11-01
- Volume
- 42
- Issue
- 11
- Pages
- 1097-1105
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2171405125
- Cited by
- 2,499
- References
- 10
- Citations by year
- 2026: 10 · 2025: 27 · 2024: 26 · 2023: 31 · 2022: 38 · 2021: 46 · 2020: 43 · 2019: 35 · 2018: 29 · 2017: 27 · 2016: 36 · 2015: 27 · 2014: 41 · 2013: 34 · 2012: 41
- FWCI
- 40.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Keywords
- Alzheimer's disease, early diagnosis, dementia, neurochemistry, neuropathology, neuroradiology, neuropsychology
- MeSH terms
- Alzheimer Disease, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review